Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma
Abstract Objective High-risk neuroblastoma patients often have poor outcomes despite multi-treatment options. The risk stratification of high-risk MYCN-not-amplified (HR-MYCN-NA) patients remains difficult. This study aims to identify a gene set signature that can help further stratify HR-MYCN-NA pa...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer
2024-09-01
|
| Cyfres: | Discover Oncology |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/s12672-024-01318-0 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
